The Use of Peripheral Blood Specimens From Patients Suspected of Having SARS-CoV-2 Infections in Research Studies Intended to Support the Development of COVID-19 Detection Methods, Treatments, and/or Vaccines
试验速览
- 阶段
- 不适用
- 入组人数
- 500
- 主要终点
- Identification of nucleic acid sequencing, antibodies and antigens to be used in detection methods or treatments and/or vaccines
研究概览
简要总结
Invivoscribe, Inc. and its wholly owned subsidiary LabPMM, LLC are collecting peripheral blood specimens from patients with suspected SARS-CoV-2 viral infections. These donors will be from a population of patients who are already providing nasal pharyngeal (NP) swab samples in universal transport media (UTM) for COVID-19 testing at LabPMM LLC. Specimens meeting this research protocol's inclusion criteria may be evaluated with various molecular techniques in order to identify nucleic acid sequences, antibodies, and/or antigens with the potential of being used to develop novel SARS-CoV-2 detection methods and COVID- 19 treatments and/or prevention methods (e.g. drug or vaccine development).
详细描述
This research protocol describes the collection and analysis of peripheral blood samples to:
- Identify nucleic acid sequences that may be used aide in the development of SARSCoV- 2 detection methods.
- Identify antibodies that may be used aide in the development of SARS-CoV-2 detection methods.
- Identify antigens that may be used aide in the development of SARS-CoV-2 detection methods. -Identify nucleic acid sequences that may be used aide in the development of COVID- 19 treatments and/or vaccines.
- Identify antibodies that may be used aide in the development of COVID-19 treatments and/or vaccines.
- Identify antigens that may be used aide in the development of COVID-19 treatments and/or vaccines.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •From patients suspected of SARS-CoV-2 viral infections.
- •From patients who have had COVID-19 testing prescribed by their treating physicians.
- •From patients whose COVID-19 test specimen was sent to LabPMM, LLC for testing
排除标准
- •There are no exclusion criteria related to age, gender, race, ethnicity, geography, and/or other medical conditions.
结局指标
主要结局
Identification of nucleic acid sequencing, antibodies and antigens to be used in detection methods or treatments and/or vaccines
时间窗: 2 years
This research protocol describes the collection and analysis of peripheral blood samples to: * Identify nucleic acid sequences that may be used aide in the development of SARSCoV- 2 detection methods. * Identify antibodies that may be used aide in the development of SARS-CoV-2 detection methods. * Identify antigens that may be used aide in the development of SARS-CoV-2 detection methods. * Identify nucleic acid sequences that may be used aide in the development of COVID- 19 treatments and/or vaccines. * Identify antibodies that may be used aide in the development of COVID-19 treatments and/or vaccines. * Identify antigens that may be used aide in the development of COVID-19 treatments and/or vaccines.
次要结局
未报告次要终点